Abstract
DHPLC (denaturing high-performance liquid chromatography) has established itself as one of the most powerful tools for DNA variation screening and allele discrimination for the characteristics of sensitivity, accuracy and efficiency that allow a rapid detection of SNPs, insertions and deletions. Moreover, it has the advantages of fullautomation and cost effectiveness. Aside from its well-known application in identifying mutations in human diseases, it has been also implemented in the quantitative measurement of gene expression and the analysis of single nucleotide extension products. In this paper, we aimed at summarizing the general properties and the main applications of DHPLC in the biomedical field as well as comparing this newly developed biotechnology with other conventional pre-screening methods for mutation scanning, such as single strand conformational polymorphisms (SSCP), conformation sensitive gel electrophoresis (CSGE) and two dimensional gene scanning (TDGS).
Keywords: DHPLC, Genetic analysis, Methylated DNA, Mitochondrial DNA, Bacterial DNA
Current Pharmaceutical Analysis
Title: Ion-Pair Reversed-Phase Denaturing HPLC-Based Biotechnology as a Tool for Genetic Analysis
Volume: 2 Issue: 3
Author(s): Maria Visalli, Isabella Venza, Mario Venza, Teresa Catalano and Diana Teti
Affiliation:
Keywords: DHPLC, Genetic analysis, Methylated DNA, Mitochondrial DNA, Bacterial DNA
Abstract: DHPLC (denaturing high-performance liquid chromatography) has established itself as one of the most powerful tools for DNA variation screening and allele discrimination for the characteristics of sensitivity, accuracy and efficiency that allow a rapid detection of SNPs, insertions and deletions. Moreover, it has the advantages of fullautomation and cost effectiveness. Aside from its well-known application in identifying mutations in human diseases, it has been also implemented in the quantitative measurement of gene expression and the analysis of single nucleotide extension products. In this paper, we aimed at summarizing the general properties and the main applications of DHPLC in the biomedical field as well as comparing this newly developed biotechnology with other conventional pre-screening methods for mutation scanning, such as single strand conformational polymorphisms (SSCP), conformation sensitive gel electrophoresis (CSGE) and two dimensional gene scanning (TDGS).
Export Options
About this article
Cite this article as:
Visalli Maria, Venza Isabella, Venza Mario, Catalano Teresa and Teti Diana, Ion-Pair Reversed-Phase Denaturing HPLC-Based Biotechnology as a Tool for Genetic Analysis, Current Pharmaceutical Analysis 2006; 2 (3) . https://dx.doi.org/10.2174/157341206777934653
DOI https://dx.doi.org/10.2174/157341206777934653 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization
Mini-Reviews in Medicinal Chemistry The Involvement of Metallothioneins in Mitochondrial Function and Disease
Current Protein & Peptide Science Testosterone and Cardioprotection Against Myocardial Ischemia
Cardiovascular & Hematological Disorders-Drug Targets Human Urotensin II and Metabolic Syndrome
Vascular Disease Prevention (Discontinued) Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Cardiac Autonomic Nervous System in Heart Failure: Imaging Technique and Clinical Implications
Current Cardiology Reviews MicroRNA-130a Regulation of Desmocollin 2 in a Novel Model of Arrhythmogenic Cardiomyopathy
MicroRNA Adult Stem Cells and Biocompatible Scaffolds as Smart Drug Delivery Tools for Cardiac Tissue Repair
Current Medicinal Chemistry Phytochemical Therapies in Vascular Functioning: A Molecular Approach
Current Vascular Pharmacology Life-history Constraints on the Mechanisms that Control the Rate of ROS Production
Current Genomics Clinical Applications for Cardiovascular Magnetic Resonance Imaging at 3 Tesla
Current Cardiology Reviews Mitochondria Damage in the Pathogenesis of Diabetic Retinopathy and in the Metabolic Memory Associated with its Continued Progression
Current Medicinal Chemistry Topoisomerase Enzymes as Therapeutic Targets for Cancer Chemotherapy
Medicinal Chemistry Pharmacological Regulators of Intracellular Calcium Release Channels
Current Pharmaceutical Design p53 Regulation of Energy Metabolism and Mitochondria Regulation of p53 in Cancer Cells: An Insight into the Role of Manganese Superoxide Dismutase
Current Pharmaceutical Biotechnology Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario
Current Topics in Medicinal Chemistry Chemistry, Physiology, and Pharmacology of β-Adrenergic Mechanisms in the Heart. Why are β-Blocker Antiarrhythmics Superior?
Current Pharmaceutical Design Targeting the Chemokines in Cardiac Repair
Current Pharmaceutical Design Regulation of Inflammation and Myocardial Fibrosis in Experimental Autoimmune Myocarditis
Inflammation & Allergy - Drug Targets (Discontinued) Inhibitory Effect of Fruit Juices on the Doxorubicin Metabolizing Activity of Carbonyl Reductase 1
Drug Metabolism Letters